2023 Quest Diagnostics Corporate Responsibility Report: CEO Jim Davis Highlights 'Care at Our Core' and Commitment to a Healthier World

Rhea-AI Summary

Quest Diagnostics' 2023 Corporate Responsibility Report, themed 'Care at Our Core', highlights the company's commitment to creating a healthier world. CEO Jim Davis emphasizes Quest's role in healthcare innovation and expansion of disease-state testing. Key achievements include:

- Acquisition of Haystack Oncology to improve cancer detection
- Expansion of Alzheimer's test portfolio
- Progress in Quest for Health Equity (Q4HE) initiative with 55 active programs
- Introduction of Quest Mobile™ phlebotomy service
- Relaunch of HealthyQuest employee health program

The report underscores Quest's focus on growth, efficiency, and new solutions to meet customer needs while expanding access to diagnostic services and reducing health disparities.

Positive

• Acquisition of Haystack Oncology to enhance early cancer detection capabilities
• Expansion of Alzheimer's test portfolio for early disease risk detection
• Introduction of Quest Mobile™ phlebotomy service, improving accessibility
• Nearly doubled the number of tests available on consumer-initiated testing platform
• Relaunch of HealthyQuest employee health program, with ~37,000 employees participating in Blueprint for Wellness®

Negative

• None.

Originally published in Quest Diagnostics' 2023 Corporate Responsibility Report

I'm pleased to share our 2023 Quest Diagnostics Corporate Responsibility Report.

NORTHAMPTON, MA / ACCESSWIRE / August 19, 2024 / The theme of this year's report is "Care at Our Core," which builds on our Purpose of working together to create a healthier world, one life at time.

Whether it's our clinical franchises innovating to expand our disease-state testing portfolio, our professional lab services business helping hospitals operate more efficiently, our phlebotomists fostering a positive experience in our patient service centers (PSCs), or our many other touchpoints across the healthcare experience, we work together every day as a team to care for our patients, customers, and one another. I am proud of the critical role we play in healthcare and how our workforce is the engine that advances innovative contributions to the field.

The Quest Way guides our Corporate Responsibility strategy and progress toward our Environmental, Social, and Governance (ESG) priorities and goals. We look forward to sharing these achievements and demonstrating how we continue to improve our processes and capabilities surrounding this work.

In 2023, we focused on generating growth, operating more efficiently, and developing new solutions to meet the needs of our primary customers. Quest remains a leading provider of advanced diagnostics, with testing services at the forefront of disease prevention, diagnosis, and monitoring. We expanded our portfolio with an emphasis on early detection. Our acquisition of Haystack Oncology will allow us to better detect residual or recurring cancers in early stages and improve treatment outcomes. We also added to our Alzheimer's test portfolio, providing individuals with insight into hereditary genetic risk and early detection of disease risk with a simple blood test.

Expanding access to our diagnostic solutions and reducing health disparities in underserved communities continued as imperatives for Quest in 2023. Through our Quest for Health Equity (Q4HE) initiative, we, along with the Quest Diagnostics Foundation, collaborated with local stakeholders on community-led efforts with 55 active programs across the country. We also made important refinements to our patient financial assistance programs, decreasing the cost of testing for qualified patients.

We introduced our mobile phlebotomy service, Quest Mobile™, and nearly doubled the number of tests available on our consumer-initiated testing platform, questhealth.com.

A healthier world starts with a healthier Quest, and a healthier Quest starts with the health of each of our ~48,000 colleagues. That's why we relaunched our employee health program, HealthyQuest, in 2023 with a renewed commitment to our colleagues' well-being. Through our Blueprint for Wellness® offering, ~37,000 Quest employees and their spouses or domestic partners received a personalized, comprehensive health report based on a lab panel, biometrics, and an online questionnaire. To further support our employees in making healthier lifestyle choices, we created a HealthyQuest Employee Business Network with more than 1,000 colleagues already participating.

2023 was a remarkable year. I am humbled to lead such a dedicated team and look forward to our continued accomplishments together.

In good health,

Jim Davis
Chairman, CEO and President

Read more

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics

View the original press release on accesswire.com

FAQ

What was the theme of Quest Diagnostics' 2023 Corporate Responsibility Report?

The theme of Quest Diagnostics' 2023 Corporate Responsibility Report was 'Care at Our Core', emphasizing the company's commitment to creating a healthier world.

How did Quest Diagnostics (DGX) expand its diagnostic portfolio in 2023?

Quest Diagnostics expanded its diagnostic portfolio in 2023 by acquiring Haystack Oncology to improve cancer detection and by adding to its Alzheimer's test portfolio for early disease risk detection.

What new service did Quest Diagnostics (DGX) introduce for improved accessibility in 2023?

Quest Diagnostics introduced Quest Mobile™, a mobile phlebotomy service, to improve accessibility to diagnostic services in 2023.

How many active programs did Quest Diagnostics' Quest for Health Equity (Q4HE) initiative have in 2023?

Quest Diagnostics' Quest for Health Equity (Q4HE) initiative had 55 active programs across the country in 2023, collaborating with local stakeholders on community-led efforts.